{
    "SPADE_N_15741": {
        "Sequence Information": {
            "Peptide Name": "Trichogin GA IV",
            "Sequence": "XGLXGGLXGI",
            "Sequence Length": 10,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Trichoderma longibrachiatum",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Trichogin GA IV: an antibacterial and protease-resistant peptide.",
                    "Pubmed ID": "19399781",
                    "Reference": "J Pept Sci. 2009;15:615-619",
                    "Author": "De Zotti M, Biondi B, Formaggio F, Toniolo C, Stella L, Park Y, Hahm KS",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19399781"
                },
                {
                    "Title": "The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity.",
                    "Pubmed ID": "25306964",
                    "Reference": "Biochim Biophys Acta. 2015;1848:134-144",
                    "Author": "Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25306964"
                },
                {
                    "Title": "The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach.",
                    "Pubmed ID": "27039838",
                    "Reference": "Sci Rep. 2016;6:24000",
                    "Author": "Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Peggion C, Bortolus M, Maniero AL",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27039838"
                }
            ],
            "SPADE ID": "SPADE_N_15741",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_07328",
                    "Similarity": 1.0,
                    "Sequence": "GLGGLGIL"
                },
                {
                    "SPADE_ID": "SPADE_N_09582",
                    "Similarity": 1.0,
                    "Sequence": "GGLGIL"
                },
                {
                    "SPADE_ID": "SPADE_N_15741",
                    "Similarity": 1.0,
                    "Sequence": "GLGGLGI"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:2% Hemolysis=15 µM,Human erythrocytes:25% Hemolysis=32 µM,Human dermal fibroblasts:50% Cell death=4 µg/ml",
            "Target Organism": "Staphylococcus aureus ATCC 25923(MIC=7.5-15µM),Staphylococcus epidermidis KCTC 3096(MIC=>30µM),Escherichia coli ATCC 25922(MIC=30µM),Pseudomonas aeruginosa KCTC 1637(MIC=>30µM),Bacillus subtilis KCTC 1918(MIC=>30µM),Listeria monocytogenes ATCC 19115(MIC=>30µM),Staphylococcus aureus CCARM 3089(IC50=6.25-12.5µM),Staphylococcus aureus CCARM 3090(IC50=>12.5µM),Staphylococcus aureus CCARM 3108(IC50=6.25-12.5µM),Staphylococcus aureus CCARM 3114(IC50=6.25-12.5µM),Staphylococcus aureus CCARM 3126(IC50=6.25-12.5µM),Fusarium oxysporum(no activity data),Rhizoctonia solani(no activity data),Aspergillus awamori(no activity data),Aspergillus parasiticus(no activity data),Aspergillus flavus(no activity data),Human cervical carcinoma HeLa(EC50=5.8±0.41µM),Human epidermoid carcinoma A431(EC50=5.8±0.41µM),Human promyelocytic leukemia HL-60(EC50=5.8±0.41µM),Human lung carcinoma A549(EC50=5.8±0.41µM),Human  glioblastoma T67(EC50=2µM)"
        }
    }
}